LAZZARONI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.532
AS - Asia 1.035
EU - Europa 660
SA - Sud America 191
AF - Africa 24
OC - Oceania 1
Totale 3.443
Nazione #
US - Stati Uniti d'America 1.485
SG - Singapore 404
CN - Cina 257
HK - Hong Kong 154
IT - Italia 153
BR - Brasile 151
DE - Germania 135
VN - Vietnam 85
FI - Finlandia 72
GB - Regno Unito 53
FR - Francia 48
UA - Ucraina 43
RU - Federazione Russa 39
TR - Turchia 33
IE - Irlanda 26
CA - Canada 23
BD - Bangladesh 21
IN - India 21
AR - Argentina 17
MX - Messico 16
SE - Svezia 15
CZ - Repubblica Ceca 10
NL - Olanda 10
PL - Polonia 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
IQ - Iraq 8
AT - Austria 7
ES - Italia 7
MK - Macedonia 7
EC - Ecuador 6
ID - Indonesia 5
JP - Giappone 5
UY - Uruguay 5
CO - Colombia 4
GR - Grecia 4
JO - Giordania 4
AL - Albania 3
BE - Belgio 3
CR - Costa Rica 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
MA - Marocco 2
PK - Pakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
TW - Taiwan 2
UG - Uganda 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MZ - Mozambico 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
Totale 3.443
Città #
Singapore 237
Ashburn 177
Hong Kong 153
San Jose 133
Fairfield 88
The Dalles 79
New York 75
Beijing 65
Munich 62
Helsinki 52
Los Angeles 50
Dallas 49
Chandler 48
Princeton 44
Houston 42
Jacksonville 37
Woodbridge 37
Seattle 36
Cambridge 34
Wilmington 34
Lauterbourg 31
Ann Arbor 29
Brescia 28
Ho Chi Minh City 28
Istanbul 28
Dublin 26
Shanghai 22
Council Bluffs 19
San Francisco 19
Hanoi 17
Milan 16
Buffalo 15
Turku 15
London 14
Redondo Beach 14
Moscow 13
San Diego 12
Chicago 11
Santa Clara 11
São Paulo 11
Des Moines 9
Frankfurt am Main 9
Nuremberg 9
Warsaw 9
Atlanta 8
Guangzhou 8
Johannesburg 8
Nanjing 8
Orem 8
Rio de Janeiro 8
Brno 7
Brooklyn 6
Montreal 6
Romola 6
Amsterdam 5
Belo Horizonte 5
Chennai 5
Crotone 5
Denver 5
Lappeenranta 5
Phoenix 5
Tianjin 5
Tokyo 5
Toronto 5
Zhengzhou 5
Amman 4
Boardman 4
Bosio 4
Changsha 4
Charlotte 4
Da Nang 4
Dosso 4
Erbil 4
Goiânia 4
Montevideo 4
Porto Alegre 4
Stockholm 4
Ankara 3
Augusta 3
Brussels 3
Calgary 3
Campinas 3
Cassina de' Pecchi 3
Catania 3
Chengdu 3
Columbus 3
Curitiba 3
Dammam 3
Dhaka 3
Duncan 3
Guayaquil 3
Hebei 3
Jinan 3
Kilburn 3
Kolkata 3
La Plata 3
Manchester 3
Mariano Comense 3
Ninh Bình 3
Ottawa 3
Totale 2.192
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 214
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 167
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 152
Long-term outcome of children born from mothers with autoimmune diseases 152
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 122
Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study 122
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 121
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome 117
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 117
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 116
Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers 114
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 112
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 110
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 110
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 107
Neurodevelopmental profile in children born to mothers affected by systemic sclerosis 106
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 104
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 103
Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis 101
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 99
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 91
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 90
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 88
Clinical Delphi on aPLnegativization: report from the from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 83
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 82
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control study 74
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 73
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 70
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 64
Long-term organ damage accrual and late mortality in systemic sclerosis 63
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 57
Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 56
Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome 54
Pulmonary Arterial Hypertension Incidence in Scleroderma Patients Treated with Bosentan for Digital Ulcers: Evidence from the Italian SPRING Registry 38
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 36
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 12
Totale 3.497
Categoria #
all - tutte 20.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 0 0 0 0 36 21 16
2021/2022222 19 33 15 12 1 14 9 15 12 31 18 43
2022/2023186 27 7 2 5 21 48 0 17 29 4 12 14
2023/2024327 20 11 33 29 12 59 11 29 62 18 9 34
2024/2025777 17 31 12 82 58 79 71 45 58 65 137 122
2025/20261.551 160 198 127 196 179 137 279 70 83 122 0 0
Totale 3.497